Holger W Auner

22PUBLICATIONS
70CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersReaction engineering (excl. nuclear reactions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 06, 2026
Targeting endoplasmic reticulum export disrupts metabolic resilience in multiple myeloma.

|Feb 23, 2026
A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.

Monica Román-Trufero, Gavin Whitlock, Claire Seydoux

|Apr 25, 2025
[AL amyloidosis : the race to diagnosis].

Nicola Ciocca, Gerasimos Tsilimidos, Holger W Auner

|Mar 03, 2025
An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation.

Mónica Román-Trufero, Istvan T Kleijn, Kevin Blighe

|Mar 29, 2024
Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.

Caroline Spertini, Alexandre P Bénéchet, Flora Birch

|Nov 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.

Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy

Pageof 4

Frequent Collaborators

4 joint publications

Meletios A Dimopoulos

3 joint publications

Anastasios Karadimitris

3 joint publications

Phillipe Moreau

3 joint publications

Eileen Gentleman